Hif-1 and human disease: One highly involved factor

Genes and Development

Volumn 14, Issue 16, 2000, Pages 1983-1991

  Semenza, G L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

ANGIOGENESIS; BRAIN ISCHEMIA; CANCER; CELL HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; GENE ACTIVATION; HEART MUSCLE ISCHEMIA; HUMAN; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RETINA ISCHEMIA; REVIEW; TRANSCRIPTION INITIATION;

ANIMALS; CARDIOVASCULAR DISEASES; FEMALE; HIV-1; HUMANS; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0034663989     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)

1. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity
2. Stabilization of wild-type p53 by hypoxia-inducible factor lα
3. Hypoxia and human placental development
4. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implication for coronary angiogenesis
5. Hypoxia-induced apoptosis: Effect of hypoxic severity and role of p53 in neuronal cell death
6. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischemia in rat brain
7. Role of hypoxia-inducible factor 1 in hypoxia-induced tolerance in neonatal rat brain
8. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase: Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning
9. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies
10. 3 restores the invasive capacity of extravillous trophoblasts in pre-eclamptic pregnancies
11. 3
12. Role of HIF-1α in hypoxiamediated apoptosis, cell proliferation, and tumour angiogenesis
13. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α
14. Cellular oxygen sensing by mitochondria: Old questions, new insight
15. 2 sensing
16. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
17. Targeting gene expression to hypoxic tumor cells
18. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signalinduced interaction with CBP/p300
19. Molecular and biological properties of vascular endothelial growth factor
20. The biology of vascular endothelial growth factor
21. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
22. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice
23. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia
24. Regulation of human placental development by oxygen tension
25. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: F1t-1, but not F1k-1/ KDR, is upregulated by hypoxia
26. The complexity of p53 modulation: Emerging patterns from divergent signals
27. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat
28. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning
29. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
30. Mutations of the VHL tumor suppressor gene in renal carcinoma
31. Identification of alternative spliced variants of human hypoxia-inducible factor-1α
32. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
33. Cancer statistics
34. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
35. Influence of coronary collaterals on myocardial infarct size in humans: Results of phase I thrombolysis in myocardial infarction (TIMI) trial
36. Antioxidant/prooxidant equilibrium regulates HIF-1α and NF- κB redox sensitivity: Evidence for inhibition by glutathione oxidation in alveolar epithelial cells
37. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53
38. Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma
39. 1 cell-cycle arrest pathways to induce glioma-like lesions in mice
40. 2-dependent degradation domain via the ubiquitin-proteasome pathway
41. Frequent co-alterations of TP53, p16/CDKN2A, p14(ARF), PTEN tumor suppressor genes in human glioma cell lines
42. 2 homeostasis by hypoxia-inducible factor 1α
43. The human hypoxia-inducible factor 1α gene: HIF1A structure and evolutionary conservation
44. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
45. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
46. Transactivation and inhibitory domains of hypoxia-inducible factor 1α: Modulation of transcriptional activity by oxygen tension
47. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes
48. Signal transduction in hypoxic cells: Inducible nuclear localization and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor- 1α
49. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
50. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
51. Hypoxial response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
52. Defective vascularization of HIF- 1α-null embryos is not associated with VEGF deficiency but with mesenchymal cell death
53. ARNT-deficient mice and placental differentiation
54. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
55. PR39, a peptide regulator of angiogenesis
56. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
57. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
58. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia
59. Cardiac hypertrophy in chronically anemic sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1
60. Hypoxia-inducible factor 1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
61. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygendependent proteolysis
62. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transciptional element
63. Loss of PTEN expression in paraffinembedded primary prostate cancer correlates with high Gleason score and advanced stage
64. ERK activation upon hypoxia: Involvement in HIF-1 activation
65. Role of hypoxia-inducible factor 1 in transcriptional activation of ceruloplasmin by iron deficiency
66. Preeclampsia prevention and management
67. Hypoxia-inducible factor 1α is increased in ischemic retina: Temporal and spatial correlation with VEGF expression
68. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
69. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
70. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
71. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the α subunit
72. Oncogenes and tumor angiogenesis: Differential modes of vascular endothelial growth factor up-regulation in rastransformed epithelial cells and fibroblasts
73. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
74. p42/p44 Mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1
75. Agedependent impairment of angiogenesis
76. Agedependent defect in VEGF expression is associated with reduced HIF-1 activity
77. Increased protein synthesis is necessary for the development of late preconditioning against myocardial stunning
78. Preeclampsia: What we know and what we do not know
79. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons
80. HIF-1α is required for solid tumor formation and embryonic vascularization
81. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
82. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends upon redox-induced changes
83. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
84. Perspectives on oxygen sensing
85. 2 homeostasis by hypoxia-inducible factor 1
86. HIF- 1: Mediator of physiological and pathophysiological responses to hypoxia
87. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
88. Development of a hypoxia-responsive vector for tumor-specific gene therapy
89. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary renal cell carcinomas
90. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
91. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
92. HIF-1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
93. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
94. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
95. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
96. Purification and characterization of hypoxia-inducible factor 1
97. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
98. Mammalian oxygen sensing, signalling and gene regulation
99. The mouse gene for hypoxia-inducible factor-1α - genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence
100. Temporal, spatial and oxygenregulated expression of hypoxia-inducible factor 1 in the lung
101. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
102. Expression of hypoxia-inducible factor 1α in human brain tumors: Association with angiogenesis, invasion, and progression
103. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
104. Modulation of HIF-1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
105. Loss of PTEN facilitates HIF-1-mediated gene expression